Paper347278
R plasmid-mediated enhancement of mutagenesis in strains of Escherichia coli deficient is known repair functions.
Venturini S and 1 other. Mutat Res, 1978. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. R plasmid-mediated enhancement of mutagenesis in strains of Escherichia coli deficient is known repair functions. Papers, record 347278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/347278
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- R plasmid-mediated enhancement of mutagenesis in strains of Escherichia coli deficient is known repair functions.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Bacterial | Major topic |
| Mutation | Major topic |
| R Factors | Major topic |
| 2-Aminopurine | |
| Cisplatin | |
| DNA Repair | |
| Escherichia coli | |
| Genotype | |
| Methyl Methanesulfonate | |
| Ultraviolet Rays |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,442,823 | Translesion DNA Synthesis. | EcoSal Plus | 2012 | https://conductscience.org/library/papers/26442823 | PubMed |
| 7,012,544 | The influence of colicinogenic plasmids ColIb-P9, ColIa-CA53 and ColV-K30 on the repair, mutagenesis and induction of colicin E1 synthesis. | Mol Gen Genet | 1981 | https://conductscience.org/library/papers/7012544 | PubMed |
| 7,000,641 | Mutagenicity of nitrofuran drugs in bacterial systems. | Folia Microbiol (Praha) | 1980 | https://conductscience.org/library/papers/7000641 | PubMed |
| 6,995,429 | Involvement of genes uvrD and recB in separate mutagenic deoxyribonucleic acid repair pathways in Escherichia coli K-12 uvrB5 and B/r uvrA155. | J Bacteriol | 1980 | https://conductscience.org/library/papers/6995429 | PubMed |
| 391,806 | Spontaneous mutational specificity of drug resistance plasmid pKM101 in Escherichia coli. | J Bacteriol | 1979 | https://conductscience.org/library/papers/391806 | PubMed |
| 377,021 | Mutagenesis and repair deficiencies of Escherichia coli umuC mutants are suppressed by the plasmid pKM101. | Mol Gen Genet | 1979 | https://conductscience.org/library/papers/377021 | PubMed |
| 370,103 | Effect of host lex, recA, recF, and uvrD genotypes on the ultraviolet light-protecting and related properties of plasmid R46 in Escherichia coli. | J Bacteriol | 1979 | https://conductscience.org/library/papers/370103 | PubMed |
| 160,001 | Uvm mutants of Escherichia coli K12 deficient in UV mutagenesis. II. Further evidence for a novel function in error-prone repair. | Mol Gen Genet | 1979 | https://conductscience.org/library/papers/160001 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/347278
GET https://conductscience.org/api/papers/v1/347278/authors